Adaptimmune Therapeutics Plc Overview

Adaptimmune Therapeutics Plc Profit Margin

Profitability ratio analysis for ADAP.

Quarterly Profit Margin

-221.83%

↓ 509.17% YoY

As of Jun 2025

Annual Profit Margin (TTM)

-260.82%

↓ 407.06% YoY

Trailing 12 months ending Jun 2025

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin